Yes , the delay cost 3 months , however .....
"The antibodies have now been successfully tested for performance, allowing the reagents to be configured into the immunoassay test kit, also known as an ELISA (enzyme linked immunosorbent assay), that can be used in clinical laboratories around the world."
Most interestingly is the updated timetable for PIQ ..... there are two licensing deals still
scheduled in December and another in Febuary....
PIQ is progressing..... and the hiring of two new Board members who have commercialisation
experience at a time when activity is increasing would seem to be justified...
All IMO.........GLTA
Yes , the delay cost 3 months , however ..... "The antibodies...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
-0.005(0.58%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.5¢ | 83.5¢ | $147.2K | 173.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18208 | 83.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 12633 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |